Search

everythinglearnresearchcommunity

for

Search:↓

The most common form of PCOS in the group was anovulatory PCOS, with no cases of obese PCOS, highlighting the importance of assessing lean women with menstrual issues.

Most women referred for excess male hormone symptoms had polycystic ovary syndrome (PCOS), with other conditions being less common.

Women with PCOS have lower physical health quality of life than those without.

Antiepileptic drugs can cause cosmetic side effects and affect menstrual cycles, fertility, and bone health in women with epilepsy.

Combination therapy significantly reduces testosterone and moderately reduces hair growth in women with hirsutism.

Ethnicity affects how polycystic ovary syndrome shows up in women, with white women having higher metabolic risks but less diabetes, and South Asian women showing more androgenic symptoms and being younger at presentation.

Mohamed Kandil suggests renaming Polycystic Ovary Syndrome to "Polyfollicular Anovulatory Androgenic Syndrome" to better describe its symptoms, but concerns exist that it may not cover all related issues like obesity and depression.

About 19.4% of Iranian women in the study have Polycystic Ovary Syndrome, with the most common type involving irregular periods and high male hormone levels, but their heart and metabolic health is similar to women without the condition.

Metformin can cause hair loss in some women with PCOS.

PCOS is a major cause of infertility in women of childbearing age.

Letrozole combined with Cabergoline improves ovulation and pregnancy rates in women with PCOS and high prolactin levels compared to Letrozole alone.

Ovulation disorders are a major cause of infertility and menstrual problems in women.

PCOS is managed by lifestyle changes and personalized medication to improve symptoms and fertility.

The document concludes that managing PCOS effectively requires considering ethnic differences, obesity's impact, and ethical concerns in treatment approaches.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

Women with epilepsy should be monitored for reproductive issues, which can be caused by epilepsy or its treatments, especially when using valproate.

Many infertile women with PCOS in Central Vietnam have metabolic or insulin resistance syndrome, with obesity and older age increasing the risk.

Chinese women with PCOS have higher androgen levels, which change with age and weight.

Married Egyptian women with PCOS have lower sexual desire compared to those without PCOS.

Treat hair loss in postmenopausal women with diet, avoiding certain drugs, and using medications like minoxidil or finasteride.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

Women with PCOS have a higher risk of diabetes and heart problems, especially when they get older.

Many young women who donate blood have hormonal disorders like excess male hormones and PCOS.

Androgens play a complex role in skin conditions like acne and hair loss in women, and normal blood levels don't always show true androgen status.

Certain metabolites are lower in women with PCOS and could be potential markers for the condition.

Women with only irregular periods or excess hair have a better hormone profile than those with full PCOS, but both groups are similar, indicating a need for better PCOS diagnosis methods.

Acne is common in women, often hormone-related, negatively affects quality of life, and requires various treatments.

South Asian women with PCOS present with different symptoms compared to White women, influenced by ethnicity, obesity, and age.

AMH is a good marker for diagnosing PCOS, but global standards are needed.